AR112975A2 - Anticuerpo humanizado - Google Patents
Anticuerpo humanizadoInfo
- Publication number
- AR112975A2 AR112975A2 ARP180102374A ARP180102374A AR112975A2 AR 112975 A2 AR112975 A2 AR 112975A2 AR P180102374 A ARP180102374 A AR P180102374A AR P180102374 A ARP180102374 A AR P180102374A AR 112975 A2 AR112975 A2 AR 112975A2
- Authority
- AR
- Argentina
- Prior art keywords
- humanized antibody
- amyloidosis
- alzheimer
- chimeric
- disorders
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 102000009091 Amyloidogenic Proteins Human genes 0.000 abstract 1
- 108010048112 Amyloidogenic Proteins Proteins 0.000 abstract 1
- 230000005856 abnormality Effects 0.000 abstract 1
- 206010002022 amyloidosis Diseases 0.000 abstract 1
- 208000035474 group of disease Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La presente está relacionada con anticuerpos quiméricos y humanizados y métodos y composiciones para uso terapéutico y de diagnóstico en el tratamiento de amiloidosis, un grupo de trastornos y anormalidades asociadas con la proteína amiloide, tal como la enfermedad de Alzheimer.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06014730 | 2006-07-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR112975A2 true AR112975A2 (es) | 2020-01-15 |
Family
ID=41040485
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170100039A AR107315A2 (es) | 2006-07-14 | 2017-01-06 | Anticuerpo humanizado |
| ARP180102374A AR112975A2 (es) | 2006-07-14 | 2018-08-21 | Anticuerpo humanizado |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170100039A AR107315A2 (es) | 2006-07-14 | 2017-01-06 | Anticuerpo humanizado |
Country Status (3)
| Country | Link |
|---|---|
| AR (2) | AR107315A2 (es) |
| UA (1) | UA100672C2 (es) |
| ZA (1) | ZA200900313B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2700104C2 (ru) * | 2014-07-10 | 2019-09-12 | Байоарктик Ньюросайенс Аб | УЛУЧШЕННЫЕ АНТИТЕЛА, СВЯЗЫВАЮЩИЕ Аβ-ПРОТОФИБРИЛЛЫ |
-
2007
- 2007-07-13 UA UAA200900880A patent/UA100672C2/ru unknown
-
2009
- 2009-01-14 ZA ZA200900313A patent/ZA200900313B/xx unknown
-
2017
- 2017-01-06 AR ARP170100039A patent/AR107315A2/es not_active Application Discontinuation
-
2018
- 2018-08-21 AR ARP180102374A patent/AR112975A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR107315A2 (es) | 2018-04-18 |
| ZA200900313B (en) | 2010-06-30 |
| UA100672C2 (en) | 2013-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20150016A (es) | Anticuerpo monoclonal | |
| PH12015500507A1 (en) | Humanized antibodies to amyloid beta | |
| WO2008011348A3 (en) | Humanized antibody against amyloid beta | |
| AU2018256498A1 (en) | Antibodies to amyloid beta | |
| AR092779A1 (es) | Composicon farmaceutica que comprende anticuerpos que se unen a conformeros de proteinas tau | |
| MY164579A (en) | Safe and functional humanized antibodies | |
| EA030777B9 (ru) | Анти-альфа-синуклеинсвязывающие молекулы | |
| EA201171388A1 (ru) | Гуманизированные антитела, специфичные к протофибриллярной форме бета-амилоидного пептида | |
| UA109633C2 (uk) | Антитіло людини проти тканинного фактора | |
| EP2650308A3 (en) | Use of anti-amyloid beta antibody in ocular diseases | |
| MX2009013503A (es) | Anticuerpo monoclonal anti-amiloide-beta. | |
| MX355268B (es) | Anticuerpos de peptido beta amiloide anti-n3pglu y usos de los mismos. | |
| MX356800B (es) | Anticuerpo tau humanizado. | |
| MX2009005743A (es) | Nuevos anticuerpos monoclonales de globulomero anti-ab selectivos del conformero ab. | |
| EP2586795A3 (en) | Use of anti-amyloid beta antibody in ocular diseases | |
| ECSP13012609A (es) | Composición farmacéutica | |
| CR20140496A (es) | Anticuerpos humanizados contra beta-amiloides | |
| CR20120491A (es) | Proteinas de unión a antigeno especificas para el componente amiloide serico p | |
| MX2013010571A (es) | Ensayo de diagnostico de anticuerpo. | |
| AR112975A2 (es) | Anticuerpo humanizado | |
| AR124605A2 (es) | Anticuerpos anti-il-36r | |
| WO2009120659A3 (en) | Human monoclonal antibodies against amyloid beta protein, and their use as therapeutic agents | |
| WO2009120657A3 (en) | Human monoclonal antibodies against amyloid beta protein, and their use as therapeutic agents | |
| EA202190387A1 (ru) | Антитело к cd38 человека и его применение |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |